Docusign, INC Form 4 insider transactions

DocuSign Director Blake Irving has reported the vesting of previously granted restricted stock units and the acquisition of new RSUs, aligning his interests with the company's long-term performance.

DocuSign Director Peter Solvik reported the vesting of 1,069 restricted stock units into common stock and the grant of 2,916 new restricted stock units, impacting his beneficial ownership.

DocuSign Director Cain A. Hayes reported the acquisition of 1,069 shares of common stock through the vesting of Restricted Stock Units (RSUs) and received a new grant of 2,916 RSUs.

DocuSign Director Anna Marrs has reported the vesting of 1,069 restricted stock units (RSUs) into common stock and the acquisition of 2,916 new RSUs, bringing her total direct common stock ownership to 9,348 shares.

DocuSign, Inc. Director James A. Beer has reported the acquisition of common stock through RSU vesting and a new grant of restricted stock units, aligning his interests with shareholders.

DocuSign Director Teresa Briggs reported the vesting of 1,069 restricted stock units (RSUs) into common stock and the acquisition of 2,916 new RSUs, as detailed in a recent SEC Form 4 filing.

DocuSign Director Mary Agnes Wilderotter reported the vesting of 1,069 restricted stock units into common stock and the grant of an additional 2,916 restricted stock units, increasing her total beneficial ownership to 57,616 shares.

DocuSign's CFO, Blake Jeffrey Grayson, recently sold shares of the company's common stock under a pre-arranged 10b5-1 trading plan.

DocuSign's CEO, Allan C. Thygesen, executed multiple sales of common stock on April 1, 2025, under a pre-arranged Rule 10b5-1 trading plan.

James P. Shaughnessy, Chief Legal Officer of DocuSign, sold a total of 7,500 shares of common stock on April 1, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Robert Chatwani, President and General Manager, Growth at Docusign, sold a portion of his common stock holdings on March 19, 2025, under a pre-arranged Rule 10b5-1 trading plan.

DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, sold shares of the company's common stock on March 19, 2025, under a pre-arranged Rule 10b5-1 trading plan.

DocuSign's CEO, Allan Thygesen, reports the vesting and disposal of restricted stock units (RSUs) and performance stock units (PSUs) to cover tax obligations.

Chief Financial Officer Blake Jeffrey Grayson of DocuSign, Inc. reports the acquisition and disposal of common stock and restricted stock units on March 15, 2025.

James P. Shaughnessy, DocuSign's Chief Legal Officer, reports the vesting and disposal of shares to cover tax obligations.

Robert Chatwani, President and General Manager of Growth at DocuSign, reports the vesting and subsequent tax withholding of shares related to restricted stock units (RSUs) and performance stock units (PSUs).

Director Daniel D. Springer reports the acquisition and disposal of DocuSign common stock and restricted stock units on March 15, 2025.

Director Teresa Briggs sold 534 shares of DocuSign (DOCU) common stock at $87.41 per share on March 17, 2025, under a pre-arranged 10b5-1 trading plan.

Director Anna Marrs reports the acquisition and disposal of DocuSign common stock and restricted stock units.

Director Enrique T. Salem reports the acquisition and disposal of Docusign common stock and restricted stock units on February 28, 2025.

Director Blake Irving reports the vesting of restricted stock units and subsequent acquisition of Docusign common stock.

Director James A. Beer reports transactions involving DocuSign common stock, including the vesting of restricted stock units.

Director Teresa Briggs reports the vesting of restricted stock units and subsequent disposal of shares.

Director Daniel D. Springer reports acquisition and disposal of DocuSign common stock and restricted stock units.

Director Peter Solvik reports the vesting and disposal of restricted stock units in Docusign, along with details of beneficial ownership.

Director Cain A. Hayes of DocuSign, Inc. reports the vesting and disposal of restricted stock units (RSUs) on February 28, 2025.

Director Mary Agnes Wilderotter reports the vesting and conversion of restricted stock units into common stock of Docusign, Inc.

DocuSign's Chief Financial Officer, Blake Jeffrey Grayson, executed sales of common stock on February 14, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Enrique T. Salem, a director at DocuSign, exercised stock options and sold 10,000 shares of common stock on January 10, 2025.

Docusign director Peter Solvik sold 10,000 shares of common stock on January 10, 2025, at an average price of $91.26.